Last reviewed · How we verify

NCT05297604

Non-Invasive Intravascular Laser Irradiation Of Blood In The Treatment Of Children With Temporomandibular Disorders

Completed NA Last updated 21 October 2024
What this trial tests

NA trial testing Vascular photobiomodulation (VPBM) in Temporomandibular Disorder in 56 participants. Completed in 10 November 2023.

Timeline
20 October 2022
Primary endpoint
20 June 2023
10 November 2023

Quick facts

Lead sponsorUniversity of Nove de Julho
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment56
Start date20 October 2022
Primary completion20 June 2023
Estimated completion10 November 2023
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Nove de Julho

Who can join

Adults 6 to 9, any sex, with Temporomandibular Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is blind, randomized controlled and have been carried out on children between 6 and 9 years of age, at the Catholic University of Uruguay, Faculty of Health Sciences, Postgraduate School, and surrounding schools. Patients who present temporomandibular disorders, based on the diagnostic criteria will be the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) were included. The laser used was infrared, power 100 mW ±20%, wavelength 660nm ±10 nm, energy parameter 60J, continuous application. The technique is not invasive, the irradiation point is by continuous and direct transcutaneous application to the radial artery by means of a bracelet that inserts the laser beam. One session has been performed. There was a laser group, a placebo group. Participants in all groups were re-evaluated after the procedure, following the same evaluation procedures used initially, evaluating the effects of ILIB on pain and range of motion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Vascular photobiomodulation in the treatment of children with temporomandibular disorders: Study protocol for a randomized, controlled, blind, clinical trial.
    Sertaje MRF, Gonçalves MLL, Gomes AO, Bruno LH, et al · · 2022 · cited 3× · PMID 36281107 · DOI 10.1097/md.0000000000031228

Verify or expand the search:

Other recruiting trials for Temporomandibular Disorder

Currently open trials in the same condition.

Other University of Nove de Julho trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing